Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC
This study is currently recruiting participants.
Verified by Seoul National University Hospital, January 2008
Sponsored by: Seoul National University Hospital
Information provided by: Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00606385
  Purpose

Short-term outcomes of laparoscopic liver resection is better than those of open liver resection

Laparoscopic liver resection is better than open resection in immunological aspects


Condition Intervention
Hepatocellular Carcinoma
Procedure: Hepatectomy

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment
Official Title: Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for Patients With Hepatocellular Carcinoma

Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • Recurrence rate [ Time Frame: 2 years after operation ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Survival [ Time Frame: 2 years after operation ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 198
Study Start Date: December 2007
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1
Laparoscopic liver resection
Procedure: Hepatectomy
Laparoscopic or Open hepatectomy
2
Open liver resection
Procedure: Hepatectomy
Laparoscopic or Open hepatectomy

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Radiologically diagnosed hepatocellular carcinoma
  • Child classification A or B
  • Aged 20 to 80
  • Informed consent taken

Exclusion Criteria:

  • Child classification C
  • Extrahepatic metastasis
  • Tumor located in central area or adjacent to middle hepatic vein
  • Recurred hepatocellular carcinoma
  • Critically ill patient
  • Patient with psychiatric disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00606385

Contacts
Contact: Ho-Seong Han, MD, PhD 82-31-787-7091 hanhs@snubh.org

Locations
Korea, Republic of, Gyeonggi-do
Seoul National University Bundang Hospital Recruiting
Seongnam, Gyeonggi-do, Korea, Republic of, 463-707
Contact: Ho-Seong Han, MD, PhD     82-31-787-7091     hanhs@snubh.org    
Principal Investigator: Ho-Seong Han, MD, PhD            
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Study Chair: Ho-Seong Han, MD, PhD Department of Surgery, Seoul National University Bundang Hospital
  More Information

Publications:
Responsible Party: Department of Surgery, Seoul National University College of Medicine ( Ho-Seong Han / Assocoate Professor )
Study ID Numbers: SNUBH-GS-HBP1, SNUBH-GS-HBP1
Study First Received: January 21, 2008
Last Updated: February 1, 2008
ClinicalTrials.gov Identifier: NCT00606385  
Health Authority: Korea: Food and Drug Administration

Keywords provided by Seoul National University Hospital:
Recurrence
Survival
Immunology
Laparoscopy

Study placed in the following topic categories:
Liver Neoplasms
Liver Diseases
Digestive System Diseases
Digestive System Neoplasms
Carcinoma, Hepatocellular
Liver neoplasms
Gastrointestinal Neoplasms
Adenocarcinoma
Recurrence
Hepatocellular carcinoma
Neoplasms, Glandular and Epithelial
Carcinoma

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Neoplasms by Histologic Type

ClinicalTrials.gov processed this record on January 16, 2009